Risperdal News
Teva Wants the FDA to Do What? - Motley Fool
In 2001 Teva filed a marketing application for its generic version of Risperdal claiming that J&J's patent was invalid. Later that year, the FDA removed the ...
Teva files suit against FDA to relist generic risperdal - CNNMoney.com
Risperdal is an antipsychotic medication used to treat schizophrenia and manic states associated with bipolar disorder. The copying, republication or ...
Teva files suit against FDA to relist generic risperdal - Interactive Investor
Risperdal is an antipsychotic medication used to treat schizophrenia and manic states associated with bipolar disorder. tf.TFN-Europe_newsdesk@thomson.com ...
FDA: Don’t Do As We Say or You’re Out of Luck - Patent Baristas
The FDA’s official Approved Drug Products with Therapeutic Equivalence Evaluations (the “Orange Book“) listed two patents as claiming Risperdal® tablets: US ...
Teva takes the FDA to court over generic Risperdal - Pharma Times (subscription)
With the lawsuit, Teva is seeking an order requiring the FDA to relist the main patent on Risperdal (risperidone) which the agency withdrew from its Orange ...
Leader: Teva's suit against FDA stands little chance: The company ... - Trading Markets (press release)
Risperdal, whose generic name is risperidone, is a treatment for schizophrenia with annual sales of some $3.5 billion. Teva announced yesterday today that ...
Ranbaxy Gets US Approval for Generic of Johnson's Risperdal - Bloomberg
By Mrinalini Datta The company received Food & Drug Administration approval for multiple strength tablets of risperidone, or generic Risperdal, ...
UPDATE 1-Teva sues FDA on generic form of J&J's Risperdal - Reuters
N: Quote, Profile, Research) Risperdal schizophrenia drug. Risperdal, which has global annual sales of about $3.5 billion, is expected to lose its US patent ...
Alkermes Provides Update on Inhaled Insulin Program - Earthtimes
Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients’ lives, manufactures RISPERDAL ® CONSTA ® for ...
Alkermes Provides Update on Inhaled Insulin Program - PharmaLive.com (press release)
Alkermes, Inc., a biotechnology company committed to developing innovative medicines to improve patients' lives, manufactures RISPERDAL(R) CONSTA(R) for ...
Risperdal RSS Feed